Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopenia.
Chong
B H
BH
Jacques
T
T
D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006440:Hemofiltration / Q000379:methods*; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate; D006801:Humans; D006435:Renal Dialysis / Q000379:methods*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy*
D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid